P4-190: the relationship between blood lipids and plasma amyloid-β is depend on blood pressure: a population-based cross-sectional study

Ningwei Hu,Ling Gao,Yu Jiang,Shan Wei,Suhang Shang,Chen Chen,Liangjun Dang,Jin Wang,Kang Huo,Meiying Deng,Jingyi Wang,Rong Zhang,Qiumin Qu

DOI: https://doi.org/10.1016/j.jalz.2019.06.3852

2019-01-01

Abstract:It is believed that deposition of amyloid-β (Aβ) in the brain is the central pathological changes of Alzheimer's disease (AD), which triggers a series of pathological processes. However, the relationship between dyslipidemia and AD is uncertainty. This was a cross-sectional study. A total of 1282 participants who met the inclusion criteria from a village in the suburbs of Xi'an, China were enrolled from Oct 8, 2014 to Mar 30, 2015. The fasting blood lipid levels and plasma Aβ levels were measured. The relationships between blood lipids and plasma levels of amyloid-β42 (Aβ42), amyloid-β40 (Aβ40) were analyzed using multiple linear regressions. In the total study population, serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) were not associated with plasma Aβ42 or Aβ40 levels (Fig1, Fig2, Tab1). However, after stratified by blood pressure, TC and LDL were positively associated with plasma Aβ42 levels (βTC=0.666, PTC=0.024; βLDL=0.743, PLDL=0.011, respectively) in normal blood pressure, but not in high blood pressure (Fig3, Tab2). LDL was negatively associated with plasma Aβ40 levels (β=−0.986, P=0.037) in high blood pressure, but not in normal blood pressure (Tab2). Other types of blood lipids unrelated to plasma Aβ(Tab2).